ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Rexahn Pharmaceuticals Inc

Rexahn Pharmaceuticals Inc (REXN)

1.81
0.00
(0.00%)
Closed 01 July 6:00AM
0.00
0.00
(0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0039.85M1.75M3.67M11.94M1.69M1.71M
Operating Income -4.94M-4.54M34.21M-6.13M-5.39M6.39M-5.43M-7.71M
Pre Tax Income -4.93M-4.53M34.26M-5.79M-4.96M5.58M-4.8M-7.11M
Net Income -4.93M-4.53M33.94M-5.79M-4.96M5.56M-4.8M-7.11M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -4.92M-4.53M34.26M-5.79M-4.96M6.84M-4.82M-7.11M
EBITDA -4.94M-4.54M34.21M-6.13M-5.39M6.39M-5.43M-7.71M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000589k39.85M19.05M
Operating Income -16.41M-17.36M-20.54M-11.22M-19.97M-22.71M18.23M-10.56M
Pre Tax Income -9.31M-25.3M-14.37M-8.64M-24.62M-56.69M18.2M-9.97M
Net Income -9.31M-25.3M-14.37M-8.64M-24.62M-56.69M17.89M-9.99M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.039-0.797-0.383-2.149-2.262-3.0080.857-0.441
EBIT -14.64M-17.36M-20.17M-11.22M-16.29M-22.86M18.21M-8.73M
EBITDA -16.38M-17.31M-20.49M-11.21M-19.96M-22.7M18.23M-10.56M